Literature DB >> 15072637

Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease.

Tessa Gordon1, Janka Hegedus, Siu Lin Tam.   

Abstract

Motor unit (MU) enlargement by sprouting is an important compensatory mechanism for loss of functional MUs during normal aging and neuromuscular disease. Perisynaptic Schwann cells at neuromuscular junctions extend processes that bridge between denervated and reinnervated endplates, and guide axonal sprouts to reinnervate the denervated endplates. In a rat model of partial denervation, high levels of daily neuromuscular activity have been shown to inhibit the outgrowth of sprouts by preventing Schwann cell bridging. In this review, we consider (1) the relative roles of increasing levels of oxidative stress and neuromuscular activity to the destabilization of neuromuscular junctions with age and disease, and (2) how a progressive increase in the neuromuscular activity of declining numbers of functional MUs contributes to the progressive failure of adaptive sprouting and, in turn, to the progressive muscle weakness in the motoneuron diseases of post-polio syndrome and amyotrophic lateral sclerosis. We conclude that there is a time-related progression of MU loss, adaptive sprouting followed by maladaptive sprouting, and continuing recession of terminals during normal aging. The progression is accelerated in motoneuron disease, progressing more rapidly in the post-polio syndrome after prolonged denervation and extremely rapidly in ALS.

Entities:  

Mesh:

Year:  2004        PMID: 15072637     DOI: 10.1179/016164104225013806

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  57 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

2.  Sprouting capacity of lumbar motoneurons in normal and hemisected spinal cords of the rat.

Authors:  T Gordon; N Tyreman
Journal:  J Physiol       Date:  2010-06-02       Impact factor: 5.182

3.  Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.

Authors:  C Tallon; K A Russell; S Sakhalkar; N Andrapallayal; M H Farah
Journal:  Neuroscience       Date:  2015-11-18       Impact factor: 3.590

4.  Manual stimulation of forearm muscles does not improve recovery of motor function after injury to a mixed peripheral nerve.

Authors:  N Sinis; O Guntinas-Lichius; A Irintchev; E Skouras; S Kuerten; S P Pavlov; H E Schaller; S A Dunlop; D N Angelov
Journal:  Exp Brain Res       Date:  2007-10-23       Impact factor: 1.972

5.  Age-related change in duration of afterhyperpolarization of human motoneurones.

Authors:  M Piotrkiewicz; L Kudina; J Mierzejewska; M Jakubiec; I Hausmanowa-Petrusewicz
Journal:  J Physiol       Date:  2007-10-11       Impact factor: 5.182

6.  MicroRNA-320 induces neurite outgrowth by targeting ARPP-19.

Authors:  Robin E White; Rona G Giffard
Journal:  Neuroreport       Date:  2012-07-11       Impact factor: 1.837

Review 7.  Mechanisms of compensatory plasticity for respiratory motor neuron death.

Authors:  Yasin B Seven; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2019-01-06       Impact factor: 1.931

Review 8.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

9.  Difference in muscle quality over the adult life span and biological correlates in the Baltimore Longitudinal Study of Aging.

Authors:  Ann Zenobia Moore; Giorgio Caturegli; E Jeffrey Metter; Sokratis Makrogiannis; Susan M Resnick; Tamara B Harris; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2014-01-17       Impact factor: 5.562

Review 10.  Aging and muscle: a neuron's perspective.

Authors:  Todd M Manini; S Lee Hong; Brian C Clark
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.